Lymph node metastasis from ductal carcinoma in situ with microinvasion

Zavotsky, Jeffry; Hansen, Nora M.; Brennan, Beatrice; Turner, Roderick R.; Giuliano, Armando E.

doi:10.1002/(sici)1097-0142(19990601)85:11<2439::aid-cncr19>3.0.co;2-j

Cited by 79 publications

(29 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pendas et al 24 reported on 87 patients with DCIS who underwent SLN biopsy; the authors found 6% of sentinel nodes positive for micrometastatic disease. Zavotsky et al, 25 reporting on 14 patients with DCISM who underwent SLN biopsy, found 14% to be positive for micrometastatic disease.…”

Section: Discussionmentioning

confidence: 99%

Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?

et al. 2000

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?

et al. 2000

View full text Add to dashboard Cite

show abstract

“…Mann et al[37] 1999 1 focus or more foci, each less or equal to 1 mm 18 0 Zavotsky et al[38] 1999 1 focus less or equal to 2 mm or up to 3 foci, each less or equal to 1 mm…”

mentioning

confidence: 99%

Microinvasive Carcinoma of the Breast

Bianchi

Vezzosi

2008

Pathol. Oncol. Res.

View full text Add to dashboard Cite

The increased rate of early detection of breast cancer due to widespread mammographic screening has led to an increased incidence not only of in situ but also microinvasive carcinoma (MC). MC has been reported to have a favourable prognosis, but specific definitions have varied in the past making the clinical significance of this entity a subject of debate. In fact, although the diagnosis of MC often appears in pathology reports, this term has not been used in a consistent, standardized manner. In addition, the histological diagnosis of MC can be problematical for the pathologist due to a variety of in situ patterns and artefacts that may be misinterpreted as stromal invasion. Definitions and diagnostic criteria of MC are reviewed and discussed. Based on a review of literature, incidence of axillary lymph node involvement, according to different definitions of microinvasion, is reported.

show abstract

Section: Quelle Est La Place Du Prélèvement Du Ganglion Sentinelle Daunclassified

“…Il est d'environ 5 % en cas de micro-invasion associée (niveau 1) [324]. En cas de CIC étendu nécessitant une mastectomie, le risque de découvrir un foyer infiltrant ou microinfiltrant est compris entre 10 et 20 % (niveau 1) [324]. Certains auteurs ont proposé d'effectuer dans cette indication une biopsie du GS (niveau 1) [67, 178,211], (niveau 2) [127].…”

Section: Quelle Est La Place Du Prélèvement Du Ganglion Sentinelle Daunclassified

“Breast Cancers” Recommendations for clinical practice from Saint Paul de Vence

2005

Oncologie

View full text Add to dashboard Cite

show abstract

Lymph node metastasis from ductal carcinoma in situ with microinvasion

Cited by 79 publications

References 9 publications

Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?

Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?

Microinvasive Carcinoma of the Breast

“Breast Cancers” Recommendations for clinical practice from Saint Paul de Vence

Contact Info

Product

Resources

About